Daniel O'Day Named Chair of PhRMA Board - Pharmaceutical Executive

Retrieved on: 2024-02-22 15:25:43

Tags for this article:

Pharmaceutical Research and Manufacturers of America

Research and development in the United States

Click the tags to see associated articles and topics

Daniel O'Day Named Chair of PhRMA Board - Pharmaceutical Executive. View article details on HISWAI: https://www.pharmexec.com/view/daniel-o-day-chair-phrma-board

Summary

This article announces Daniel O'Day of Gilead Sciences as the new chair of the Pharmaceutical Research and Manufacturers of America (PhRMA), highlighting the biopharma industry's leadership changes and commitment to innovation and patient access to medicines.

Article found on: www.pharmexec.com

View Original Article